According to Gram Research analysis, a protein called LUR1 accelerates cholesterol buildup in immune cells and artery disease by activating two other proteins, furin and sortilin. In mice with elevated LUR1, total cholesterol, triglycerides, and LDL cholesterol all increased, and plaque deposits in arteries expanded significantly compared to control mice.
Researchers discovered that a protein called LUR1 plays a sneaky role in heart disease by helping cholesterol build up inside immune cells in your arteries. Using lab experiments and mice, scientists found that LUR1 works with two other proteins to make cells absorb more bad cholesterol, which leads to plaque formation in blood vessels. This discovery, published in 2026, could eventually help doctors develop new treatments to slow down or prevent atherosclerosis, the hardening of arteries that causes heart attacks and strokes.
Key Statistics
A 2026 research article found that increasing LUR1 expression in immune cells enhanced the maturation of sortilin and furin, leading to greater cholesterol uptake and accumulation within those cells.
In male mice with extra LUR1 fed a high-fat diet, plasma levels of total cholesterol, triglycerides, and LDL cholesterol all elevated, and atherosclerotic plaque area in vessel walls increased compared to control mice.
Co-immunoprecipitation assays confirmed direct binding between LUR1 and furin, establishing a physical interaction between these two proteins in the cellular pathway controlling cholesterol metabolism.
The Quick Take
- What they studied: How a protein called LUR1 helps cholesterol get trapped inside immune cells and causes artery disease
- Who participated: Lab experiments used human immune cells grown in dishes and male mice that were genetically designed to develop heart disease when eating a high-fat diet
- Key finding: When LUR1 levels increased, mice developed more plaque buildup in their arteries and had higher cholesterol levels in their blood
- What it means for you: This research identifies a new target for future heart disease treatments, though it’s still in early stages and not yet applicable to human patients
The Research Details
Scientists used multiple approaches to understand how LUR1 affects heart disease. First, they used computer analysis to predict how LUR1 might interact with other proteins involved in cholesterol handling. Then they grew human immune cells in laboratory dishes and added extra copies of the LUR1 gene to see what happened. They measured how much fat accumulated inside these cells and looked at the proteins involved in cholesterol uptake. Finally, they tested their findings in mice that were bred to develop heart disease, giving some mice extra LUR1 through a viral delivery system while feeding all mice a high-fat diet to trigger plaque formation.
The researchers examined artery tissue from the mice using special staining techniques to visualize plaque buildup. They also measured cholesterol and triglyceride levels in the mice’s blood using standard lab methods. This combination of cell studies and animal experiments allowed them to trace how LUR1 affects the entire process from cholesterol uptake to artery disease development.
The study focused specifically on the Golgi apparatus, a cellular structure that packages and processes proteins. LUR1 is located in this area and appears to control how other proteins mature and become active.
Understanding the specific proteins involved in cholesterol accumulation is crucial because it reveals potential drug targets. Rather than just lowering cholesterol levels broadly, future treatments could specifically block LUR1 or its interactions to prevent immune cells from absorbing excessive cholesterol. This targeted approach might be more effective and have fewer side effects than current treatments.
The study used well-established research techniques including gene expression analysis, protein detection methods, and animal models commonly used in cardiovascular research. The researchers confirmed their findings using multiple approaches, which strengthens confidence in the results. However, the study was conducted in laboratory and animal settings, so results may not directly translate to humans. The specific sample sizes for cell experiments and the exact number of mice used were not detailed in the abstract.
What the Results Show
When researchers increased LUR1 levels in immune cells, the cells absorbed significantly more cholesterol. The protein LUR1 worked by helping two other proteins, furin and sortilin, become fully active and mature. This maturation process was confirmed through a technique called co-immunoprecipitation, which showed that LUR1 physically binds to furin.
In mice with extra LUR1, blood cholesterol levels rose substantially, including increases in total cholesterol, triglycerides, and LDL cholesterol (the bad kind). The mice also developed larger plaque deposits in their arteries compared to control mice. These effects occurred even though all mice were eating the same high-fat diet, suggesting that LUR1 specifically accelerates the disease process.
The researchers found that LUR1 enhanced the conversion of inactive protein forms into active ones. Specifically, it reduced the ratio of inactive furin to active furin, and similarly reduced the ratio of inactive sortilin to total sortilin. This activation cascade appears to be the mechanism by which LUR1 drives cholesterol accumulation.
The study confirmed that LUR1, furin, and sortilin all work together as a coordinated system. When LUR1 increased, the expression levels of both furin and sortilin also increased, suggesting these proteins regulate each other. The research also demonstrated that this process occurs in the Golgi apparatus, a specific cellular compartment, which narrows down where future drug interventions might need to target.
This research builds on existing knowledge that sortilin and furin play roles in cholesterol metabolism and atherosclerosis. The novel contribution is identifying LUR1 as a key regulator that controls how these proteins mature and function. Previous studies showed that sortilin helps cells take up oxidized LDL (damaged cholesterol), but this is the first work to clearly demonstrate LUR1’s role in activating sortilin through furin maturation.
The study was conducted in laboratory cells and mice, not in humans, so the findings may not directly apply to human heart disease. The mice used were genetically modified to develop atherosclerosis, which may not perfectly mirror the disease in people. The research focused on one specific pathway and didn’t examine whether blocking LUR1 would actually prevent or reverse atherosclerosis. Additionally, the abstract doesn’t provide complete details about sample sizes for the cell experiments or the number of mice used in each group.
The Bottom Line
This research is preliminary and should not yet influence personal health decisions. Current evidence-based approaches to preventing heart disease remain diet modification, exercise, stress management, and medications like statins if prescribed by a doctor. This study suggests a future direction for drug development but is not ready for clinical application. Confidence level: Low for human application, as this is early-stage research.
People at high risk for heart disease, cardiologists, and pharmaceutical researchers should follow this line of investigation. People currently managing cholesterol should continue following their doctor’s recommendations while this research progresses. This finding is not yet relevant for individual treatment decisions.
This research is in the basic science phase. Even if LUR1 proves to be a viable drug target, it typically takes 10 to 15 years to develop and test new medications in humans. Realistic expectations are that this work will inform future research directions rather than lead to immediate clinical treatments.
Frequently Asked Questions
What is LUR1 and why does it matter for heart disease?
LUR1 is a protein that helps activate other proteins involved in cholesterol uptake by immune cells. When LUR1 levels are high, cells absorb more bad cholesterol, leading to plaque buildup in arteries and atherosclerosis.
Can I get tested for LUR1 levels to know my heart disease risk?
Not yet. LUR1 testing is not available clinically because this research is still in early stages. Current heart disease risk assessment uses cholesterol levels, blood pressure, and other established markers.
Will there be a drug to block LUR1 soon?
This research identifies LUR1 as a potential drug target, but developing and testing new medications typically takes 10 to 15 years. Current cholesterol-lowering medications like statins remain the proven treatment.
Does this mean I should change my diet or exercise routine?
No. This basic research doesn’t change current heart disease prevention recommendations. Continue following your doctor’s advice on diet, exercise, and medications while researchers develop new treatments based on findings like this.
How does LUR1 work to increase cholesterol in cells?
LUR1 activates two proteins called furin and sortilin that work together to help immune cells absorb more oxidized LDL cholesterol. This activation process happens inside a cellular compartment called the Golgi apparatus.
Want to Apply This Research?
- Track your cholesterol levels (total, LDL, HDL, and triglycerides) every 3 to 6 months as recommended by your doctor, noting the date and values to monitor trends over time
- Use the app to log daily heart-healthy habits like aerobic exercise (150 minutes per week), servings of vegetables, and adherence to prescribed medications, which remain the proven ways to manage cholesterol while researchers develop new treatments
- Set quarterly reminders to review your cholesterol panel results and discuss any changes with your healthcare provider, while monitoring emerging research on new atherosclerosis treatments
This research is preliminary laboratory and animal study work and has not been tested in humans. It does not provide guidance for individual medical decisions. Anyone with concerns about heart disease risk should consult their healthcare provider about appropriate screening and treatment options. Current evidence-based approaches to preventing atherosclerosis include diet modification, regular exercise, stress management, and medications prescribed by a doctor. This article is for educational purposes only and should not be considered medical advice.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.